Press

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

Sep 5 • 3 min read

BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that Technology Networks Drug Discovery, in its September 1, 2023 issue, has published an article entitled “Exploring the LSD-Derivative With Potential for Treating Mood Disorders”. The article discusses the potential…

Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Sep 5 • 2 min read

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA and high-quality, GMP-grade natural psilocybin, is pleased to announce it has entered into a non-dilutive Debt Financing Agreement (“DFA”) and General Security Agreement…

Cybin Announces Grant of U.S. Patent Covering Deuterated Tryptamines

Sep 5 • 3 min read

– Newly granted U.S. patent further strengthens the Company’s leadership position in the deuterated tryptamine space – – With the recently announced definitive agreement to acquire Small Pharma Inc. The granted patent will add to the most impressive intellectual property portfolio in the psychedelic drug development sector with 29 patents granted and over 150 patents…

MindBio Therapeutics Corp. Announces Major Genetic Discovery in Microdosing Research

Sep 5 • 3 min read

MindBio Therapeutics Corp. reported it has made a major discovery from genetic testing clinical trial participants in the largest LSD-Microdosing randomized double blind and placebo-controlled trial ever completed. The data analysis comes as the Company begins two Phase 2 clinical trials using its proprietary form of LSD for Microdosing MB22001. These trials are a world…

California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments

Sep 1 • 4 min read

California’s psychedelic decriminalisation bill, SB-58, was passed with amendments by the Assembly Appropriations Committee. Its amended version will now head to the assembly floor for a final vote before going to the Governor’s desk. The bill was passed as part of the California Assembly Appropriations Committee’s ‘suspense day’, whereby bills placed on the suspense file…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435